Summary:
The Respire study is a 12 month clinical trial on an FDA-approved drug for COPD patients.
You may qualify to participate if you are:
- Over the age of 40
- A current or former smoker
- Diagnosed with chronic pulmonary obstructive disorder (COPD)
Participants may receive Perforomist® Inhalation Solution or placebo, 1 year of study-related care and monitoring from a local doctor experienced in respiratory disease, and up to $800 compensation for time and travel.